Molecular mechanisms of insulin resistance in 2 cases of primary insulin receptor defect-associated diseases. 2017

Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan.

BACKGROUND Defects of the insulin receptor gene ( INSR ) cause wide spectra of congenital insulin resistance. Monoallelic defects result in milder insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN, type A). Whereas, leprechaunism (Donahue syndrome), the most severe condition with lethality during the infantile period is caused by biallelic defects of INSR . METHODS We detected 2 missense mutations in 2 cases of leprechaunism and IRAN, type A, and reduced mRNA expression in the leprechaunism case. We performed an in vitro analysis to confirm that the 2 missense mutations are causative. RESULTS The heterozygote mutations c.3436G>A (p.Gly1146Arg) and c.294C>A (p.Ser98Arg) were identified in a male patient with IRAN, type A and a female patient with leprechaunism, respectively. Gly1146Arg was previously reported in a diabetic case without precise functional analyses, and Ser98Arg is a novel mutation. Gly1146 and Ser98 are located on the tyrosine kinase domain and ligand-binding domain of INSR, respectively, and in vitro analyses (assay for insulin binding and phosphorylation) revealed that each mutation disrupted protein functions and properties. In the leprechaunism case, mutations in INSR other than Ser98Arg were not identified, and qRT-PCR analysis revealed that mRNA expression of INSR in lymphocytes was reduced in the leprechaunism case. CONCLUSIONS Our study indicates that the 2 missense mutations of INSR , Gly1146Arg, and Ser98Arg, are responsible for insulin resistance, and, suggests that mutations not contained within INSR , but leading to decreased INSR expression should be considered for the patients who show insulin resistance without any mutations in the coding sequence of INSR.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000052 Acanthosis Nigricans A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder. Acanthosis Nigrican,Nigrican, Acanthosis,Nigricans, Acanthosis
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation

Related Publications

Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
January 2007, Clinica chimica acta; international journal of clinical chemistry,
Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
October 1986, Metabolism: clinical and experimental,
Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
September 2003, Diabetes,
Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
July 2010, World journal of diabetes,
Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
December 1984, The Journal of biological chemistry,
Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
April 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
June 2005, Diabetic medicine : a journal of the British Diabetic Association,
Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
May 1991, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
October 2009, Archives of physiology and biochemistry,
Atsumi Tsuji-Hosokawa, and Kei Takasawa, and Risa Nomura, and Yuichi Miyakawa, and Chikahiko Numakura, and Atsushi Hijikata, and Tsuyoshi Shirai, and Yoshihiro Ogawa, and Kenichi Kashimada, and Tomohiro Morio
May 1988, Zhonghua yi xue za zhi,
Copied contents to your clipboard!